1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR
Novo Nordisk - ADR XNYS: NVO
Slowing Down Stock
50.03 -3.91 (-7.25%)
New 52W Low today
65.7M
XNYS Volume
High volume+loss today

XNYS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
CEO Appointment
Novo Nordisk names insider Maziar Doustdar as CEO after Wegovy sales slump in Q2 See details

Detailed Stock Analysis for Novo Nordisk - ADR with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in